openPR Logo
Press release

Botulinum Toxin Market To Grow in the Coming Years, New Research explores Factors Responsible | Global Players Include Ipsen group, Allergan Plc., Medytox Inc., Merz GmbH and Co. KGaA, US Worldmed, LLC, Revance Therapeutics, Inc.

01-14-2019 04:05 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Global Botulinum Toxin Market

Global Botulinum Toxin Market

Botulinum toxin is a product produced by naturally occurring Clostridium botulinum bacteria. This bacteria is found in soil and marine sediments and can produce harmful neurotoxin botulinum toxin. Botulinum toxin is a ‘blocking agent’ which inhibits the release of certain neurotransmitters, specifically acetylcholine, from the endings of the motor nerves. There are about eight types of botulinum toxin named from type A to H. Botulinum toxin type A and botulinum toxin type B are majorly used in cosmetic procedures for the treatment of various facial conditions, its commercially marketed under the brand name Botox. Botulinum toxin type A and B are also used in medical applications for treatment of various diseases such as dystonia, chronic migraines, and spasticity.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1518

Botulinum Toxin Market: Drivers

Frequent approvals of novel botulinum toxin products for different indications are expected to drive growth of the Botulinum toxin market in near future. For instance, in 2016, Ipsen S.A. received the U.S. Food and Drug Administration (FDA) approval for its Dysport (abobotulinumtoxinA) injection indicated for the treatment of pediatric lower limb (PLL) spasticity in children of age two years and older. In 2017, company received the FDA approval for same product to use in adults. In 2017, Allergan plc. received FDA approval for BOTOX Cosmetic (OnabotulinumtoxinA) for new indication in forehead lines, and previously the product has been approved for the treatment of , crow's feet lines, and glabellar lines. With this approval company has expanded the indication of its product in the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults.

Botulinum Toxin Market: Regional analysis

North America is expected to hold a dominant position in the global botulinum toxin market, owing to increasing trend of cosmetic procedures in the region. For instance, according to a report published by American Society of Plastic Surgeons in 2016, around US$ 16.4 billion was spent on cosmetic procedures in the U.S. and in 2017, around 7.2 million botulinum injections were used in the U.S. for cosmetic procedures. Increasing number of cosmetic procedures in the key region of North America is expected to drive the growth of the botulinum toxin market in near future. Furthermore, Asia Pacific is expected to show rapid growth in botulinum toxin market, owing to increasing R&D and approval of novel products in China. For instance, in January 2018, Daewoong Pharmaceutical Co. Ltd., a Korean company, received approval from the Chinese authorities to conduct clinical trials for botulinum toxin Nabota in China.

Botulinum Toxin Market: Key Players

Key players operating in global botulinum toxin market includes Ipsen group, Allergan Plc., Medytox Inc., Merz GmbH and Co. KGaA, US Worldmed, LLC, Lanzhou Institute of Biological Products Co. Ltd., Revance Therapeutics, Inc., and Daewoong Pharmaceutical Co., Ltd. Major players in market are involved in strategic collaborations to develop new products. For instance, in February 2018, Mylan N.V. and Revance Therapeutics, Inc. underwent strategic collaboration and license agreement for the development and commercialization of a proposed biosimilar to BOTOX (onabotulinumtoxinA). Furthermore, key players are focusing on receiving approvals of its product in key market to expand their presence in global market. For instance, in February 2018, Medytox Inc. filed a new drug application with the China Food and Drug Administration (CFDA) to its botulinum neurotoxin product Meditoxin in China.

Botulinum Toxin Market: Market Taxonomy

The global botulinum toxin market has been segmented based on product type, application, distribution channel, and geography:

By Product Type:

Botulinum Toxin Type A
Botulinum Toxin Type B

By Application:

Cosmetics
Dystonia
Chronic Migraines
Spasticity
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Geography:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1518

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Botulinum Toxin Market To Grow in the Coming Years, New Research explores Factors Responsible | Global Players Include Ipsen group, Allergan Plc., Medytox Inc., Merz GmbH and Co. KGaA, US Worldmed, LLC, Revance Therapeutics, Inc. here

News-ID: 1495960 • Views:

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 2026 : Key Players are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2026
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Research Report 2018-2026
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insignificant CAGR Till 2025 With Top Players Novartis AG, Celgene Corp, Otsuka Pharmaceutical Co., Sandoz, Dr Reddys Laboratories, Pharmascience
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Botulinum

Botulinum Toxin Market Overview Segmentation Analysis Forecast To 2028
The latest report by Precision Business Insights, titled "Botulinum Toxin Market" covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints. The global botulinum toxin market size was valued at USD 3.42 billion in 2021 and is poised to grow at a significant CAGR of 7.5% during the forecast period 2022-2028. The Botulinum Toxin Market Overview: A byproduct of naturally occurring Clostridium botulinum bacterium is botulinum
Botulinum Toxin Market 2019 | Key Player Profiles by 2025
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Botulinum Toxin market. It includes Porter’s Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Botulinum Toxin Market. We have provided deep analysis of the vendor landscape to give you a
Global Botulinum Neurotoxins Market Research Report
This report studies the global Botulinum Neurotoxins market status and forecast, categorizes the global Botulinum Neurotoxins market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Johnson & Johnson GSK Allergan Chong Kun Dang Eisai Nestle Galderma Ipsen Hugel Mentor CROMA Alphaeon OBI
Botulinum Toxin Market: Adoption of Non-Surgical Botulinum Toxin to Favor Growth …
The botulinum toxin market growth is strongly underpinned by rising investment towards the development of novel therapeutic applications of botulinum toxin. Additionally, surged cosmetic expenditure owing to elevated disposable income across regions further widen growth scope. However, prevalence of various side effects coupled with high pricing are likely to stunt market growth significantly. Market Research Hub (MRH) has recently added a new business intelligence report titled, ‘Botulinum Toxin Market - Global
Botulinum Toxin Market - Global Industry Insights, 2026
Botulinum toxin is a product produced by naturally occurring Clostridium botulinum bacteria. This bacteria is found in soil and marine sediments and can produce harmful neurotoxin botulinum toxin. Botulinum toxin is a ‘blocking agent’ which inhibits the release of certain neurotransmitters, specifically acetylcholine, from the endings of the motor nerves. There are about eight types of botulinum toxin named from type A to H. Botulinum toxin type A and botulinum
Botulinum Toxin Market highly efficient technology developed by 2025
Global Botulinum Toxin Market: Snapshot Botulinum toxin, known to the mankind as one of the most poisonous biological substances, is a neurotoxin produced by the Clostridium botulinum bacteria. Clostridium botulinum, the gram-positive, anaerobic, spore-forming bacteria commonly found in water, soil, on plants, and the intestinal tracts of animals can be elaborated into eight exotoxins, all interfering with the process of neural transmission and causing muscle paralysis. From the earliest recorded uses of